A citation-based method for searching scientific literature

Daphne Vassiliou, Eliane Sardh, Pauline Harper, Amy R Simon, Valerie A Clausen, Nader Najafian, Gabriel J Robbie, Sagar Agarwal. Clin Pharmacol Ther 2021
Times Cited: 7







List of co-cited articles
64 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.
Manisha Balwani, Eliane Sardh, Paolo Ventura, Paula Aguilera Peiró, David C Rees, Ulrich Stölzel, D Montgomery Bissell, Herbert L Bonkovsky, Jerzy Windyga, Karl E Anderson,[...]. N Engl J Med 2020
162
71

Systemic messenger RNA as an etiological treatment for acute intermittent porphyria.
Lei Jiang, Pedro Berraondo, Daniel Jericó, Lin T Guey, Ana Sampedro, Andrea Frassetto, Kerry E Benenato, Kristine Burke, Eva Santamaría, Manuel Alegre,[...]. Nat Med 2018
77
57

Dysregulation of homocysteine homeostasis in acute intermittent porphyria patients receiving heme arginate or givosiran.
Jordi To-Figueras, Robin Wijngaard, Judit García-Villoria, Aasne K Aarsand, Paula Aguilera, Ramon Deulofeu, Mercè Brunet, Àlex Gómez-Gómez, Oscar J Pozo, Sverre Sandberg. J Inherit Metab Dis 2021
22
57


RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice.
Makiko Yasuda, Lin Gan, Brenden Chen, Senkottuvelan Kadirvel, Chunli Yu, John D Phillips, Maria I New, Abigail Liebow, Kevin Fitzgerald, William Querbes,[...]. Proc Natl Acad Sci U S A 2014
83
57

Benefits of prophylactic heme therapy in severe acute intermittent porphyria.
Pradeep Yarra, Denise Faust, Mary Bennett, Sean Rudnick, Herbert L Bonkovsky. Mol Genet Metab Rep 2019
16
57

Severe homocysteinemia in two givosiran-treated porphyria patients: is free heme deficiency the culprit?
Petro E Petrides, Michael Klein, Elfriede Schuhmann, Heike Torkler, Brigitte Molitor, Christian Loehr, Zahra Obermeier, Maria K Beykirch. Ann Hematol 2021
19
57

Renal Function Decline With Small Interfering RNA Silencing Aminolevulinic Acid Synthase 1 (ALAS1).
Hélène Lazareth, Antoine Poli, Yohan Bignon, Arienne Mirmiran, Marion Rabant, Raphaël Cohen, Caroline Schmitt, Hervé Puy, Alexandre Karras, Laurent Gouya,[...]. Kidney Int Rep 2021
11
57

From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria.
Hugo Lenglet, Caroline Schmitt, Thomas Grange, Hana Manceau, Narjesse Karboul, Florian Bouchet-Crivat, Anne-Marie Robreau, Gael Nicolas, Jerôme Lamoril, Sylvie Simonin,[...]. Hum Mol Genet 2018
46
42

High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria.
Nicolas Pallet, Iadh Mami, Caroline Schmitt, Zoubida Karim, Arnaud François, Marion Rabant, Dominique Nochy, Laurent Gouya, Jean-Charles Deybach, Yichum Xu-Dubois,[...]. Kidney Int 2015
57
42

Pharmacokinetics and Pharmacodynamics of the Small Interfering Ribonucleic Acid, Givosiran, in Patients With Acute Hepatic Porphyria.
Sagar Agarwal, Amy R Simon, Varun Goel, Bahru A Habtemariam, Valerie A Clausen, Jae B Kim, Gabriel J Robbie. Clin Pharmacol Ther 2020
46
42

Experiences and concerns of patients with recurrent attacks of acute hepatic porphyria: A qualitative study.
Hetanshi Naik, Mikayla Stoecker, Saskia C Sanderson, Manisha Balwani, Robert J Desnick. Mol Genet Metab 2016
40
42

Liver Transplantation for Acute Intermittent Porphyria.
Mattias Lissing, Greg Nowak, René Adam, Vincent Karam, Alexander Boyd, Laurent Gouya, Wouter Meersseman, Espen Melum, Urszula Ołdakowska-Jedynak, Florian P Reiter,[...]. Liver Transpl 2021
14
42

Heme biosynthesis and the porphyrias.
John D Phillips. Mol Genet Metab 2019
47
42

Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification.
Amy Chan, Abigail Liebow, Makiko Yasuda, Lin Gan, Tim Racie, Martin Maier, Satya Kuchimanchi, Don Foster, Stuart Milstein, Klaus Charisse,[...]. Mol Ther Nucleic Acids 2015
84
42


Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria.
Eliane Sardh, Pauline Harper, Manisha Balwani, Penelope Stein, David Rees, D Montgomery Bissell, Robert Desnick, Charles Parker, John Phillips, Herbert L Bonkovsky,[...]. N Engl J Med 2019
126
42

Reconstitution of hematin for intravenous infusion.
Karl E Anderson, Herbert L Bonkovsky, Joseph R Bloomer, Steven I Shedlofsky. Ann Intern Med 2006
26
42

EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks.
Laurent Gouya, Paolo Ventura, Manisha Balwani, D Montgomery Bissell, David C Rees, Ulrich Stölzel, John D Phillips, Raili Kauppinen, Janneke G Langendonk, Robert J Desnick,[...]. Hepatology 2020
54
42

Liver Fibrosis Associated with Iron Accumulation Due to Long-Term Heme-Arginate Treatment in Acute Intermittent Porphyria: A Case Series.
Barbara Willandt, Janneke G Langendonk, Katharina Biermann, Wouter Meersseman, François D'Heygere, Christophe George, Chris Verslype, Diethard Monbaliu, David Cassiman. JIMD Rep 2016
30
42

Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing.
Jayaprakash K Nair, Jennifer L S Willoughby, Amy Chan, Klaus Charisse, Md Rowshon Alam, Qianfan Wang, Menno Hoekstra, Pachamuthu Kandasamy, Alexander V Kel'in, Stuart Milstein,[...]. J Am Chem Soc 2014
539
42

Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin.
H L Bonkowsky, D P Tschudy, A Collins, J Doherty, I Bossenmaier, R Cardinal, C J Watson. Proc Natl Acad Sci U S A 1971
189
42

Therapeutic siRNA: state of the art.
Bo Hu, Liping Zhong, Yuhua Weng, Ling Peng, Yuanyu Huang, Yongxiang Zhao, Xing-Jie Liang. Signal Transduct Target Ther 2020
227
42

Porphyria.
D Montgomery Bissell, Karl E Anderson, Herbert L Bonkovsky. N Engl J Med 2017
154
42

Acute intermittent porphyria, givosiran, and homocysteine.
Antonio Fontanellas, Matías A Ávila, Elena Arranz, Rafael Enríquez de Salamanca, Montserrat Morales-Conejo. J Inherit Metab Dis 2021
8
42

Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study.
Paolo Ventura, Herbert L Bonkovsky, Laurent Gouya, Paula Aguilera-Peiró, D Montgomery Bissell, Penelope E Stein, Manisha Balwani, D Karl E Anderson, Charles Parker, David J Kuter,[...]. Liver Int 2022
9
42

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.
David Adams, Alejandra Gonzalez-Duarte, William D O'Riordan, Chih-Chao Yang, Mitsuharu Ueda, Arnt V Kristen, Ivailo Tournev, Hartmut H Schmidt, Teresa Coelho, John L Berk,[...]. N Engl J Med 2018
42

Evaluation of gonadotropin-releasing hormone agonist treatment for prevention of menstrual-related attacks in acute porphyria.
Eva Innala, Torbjörn Bäckström, Marie Bixo, Christer Andersson. Acta Obstet Gynecol Scand 2010
35
28


Audit of the Use of Regular Haem Arginate Infusions in Patients with Acute Porphyria to Prevent Recurrent Symptoms.
Joanne T Marsden, Simon Guppy, Penelope Stein, Timothy M Cox, Michael Badminton, Tricia Gardiner, Julian H Barth, M Felicity Stewart, David C Rees. JIMD Rep 2015
43
28

Sustained high plasma 5-aminolaevulinic acid concentration in a volunteer: no porphyric symptoms.
P Mustajoki, K Timonen, A Gorchein, A M Seppäläinen, E Matikainen, R Tenhunen. Eur J Clin Invest 1992
47
28

Acute Intermittent Porphyria: Predicted Pathogenicity of HMBS Variants Indicates Extremely Low Penetrance of the Autosomal Dominant Disease.
Brenden Chen, Constanza Solis-Villa, Jörg Hakenberg, Wanqiong Qiao, Ramakrishnan R Srinivasan, Makiko Yasuda, Manisha Balwani, Dana Doheny, Inga Peter, Rong Chen,[...]. Hum Mutat 2016
78
28

Preliminary report: hyperhomocysteinemia in patients with acute intermittent porphyria.
Jordi To-Figueras, Rosa Maria Lopez, Ramon Deulofeu, Carmen Herrero. Metabolism 2010
19
28

Development of the "Inje cocktail" for high-throughput evaluation of five human cytochrome P450 isoforms in vivo.
J Y Ryu, I S Song, Y E Sunwoo, J H Shon, K H Liu, I J Cha, J G Shin. Clin Pharmacol Ther 2007
98
28


Feasibility of cellular bioenergetics as a biomarker in porphyria patients.
Balu Chacko, Matilda Lillian Culp, Joseph Bloomer, John Phillips, Yong-Fang Kuo, Victor Darley-Usmar, Ashwani K Singal. Mol Genet Metab Rep 2019
13
28


Patient Perspective on Acute Intermittent Porphyria with Frequent Attacks: A Disease with Intermittent and Chronic Manifestations.
Amy Simon, Farrah Pompilus, William Querbes, Alex Wei, Sara Strzok, Craig Penz, Desiree Lyon Howe, Jessica R Hungate, Jae B Kim, Sonalee Agarwal,[...]. Patient 2018
33
28

Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver.
C Schmitt, H Lenglet, A Yu, C Delaby, A Benecke, T Lefebvre, P Letteron, V Paradis, S Wahlin, S Sandberg,[...]. J Intern Med 2018
57
28

Update review of the acute porphyrias.
Penelope E Stein, Michael N Badminton, David C Rees. Br J Haematol 2017
70
28

Porphyria and kidney diseases.
Nicolas Pallet, Alexandre Karras, Eric Thervet, Laurent Gouya, Zoubida Karim, Hervé Puy. Clin Kidney J 2018
24
28

Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium.
Herbert L Bonkovsky, Vinaya C Maddukuri, Cemal Yazici, Karl E Anderson, D Montgomery Bissell, Joseph R Bloomer, John D Phillips, Hetanshi Naik, Inga Peter, Gwen Baillargeon,[...]. Am J Med 2014
119
28

Role of delta-aminolevulinic acid in the symptoms of acute porphyria.
D Montgomery Bissell, Jennifer C Lai, Raymond K Meister, Paul D Blanc. Am J Med 2015
54
28

An update of clinical management of acute intermittent porphyria.
Elena Pischik, Raili Kauppinen. Appl Clin Genet 2015
91
28


Combined liver and kidney transplantation in acute intermittent porphyria.
Staffan Wahlin, Pauline Harper, Eliane Sardh, Christer Andersson, Dan Eh Andersson, Bo-Göran Ericzon. Transpl Int 2010
52
28

Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha.
Christoph Handschin, Jiandie Lin, James Rhee, Anne-Kathrin Peyer, Sherry Chin, Pei-Hsuan Wu, Urs A Meyer, Bruce M Spiegelman. Cell 2005
240
28

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.
A Fire, S Xu, M K Montgomery, S A Kostas, S E Driver, C C Mello. Nature 1998
28

Givosiran: First Approval.
Lesley J Scott. Drugs 2020
137
28

The growth of siRNA-based therapeutics: Updated clinical studies.
M May Zhang, Raman Bahal, Theodore P Rasmussen, José E Manautou, Xiao-Bo Zhong. Biochem Pharmacol 2021
67
28


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.